Showing results (191-200 of 279) with videos related to

Sort By:
Pageof 28
Current Biology : CB|June 19, 2026
Phosphorus stress and spatial confinement lower the quorum-sensing activation threshold for phenazine production in PseudomonassynxanthaReinaldo E Alcalde, Hannah Jeckel, Oumeng Zhang, et al.
Transplantation|March 5, 2019
Antibody-suppressor CD8+ T Cells Require CXCR5Jason M Zimmerer, Bryce A Ringwald, Steven M Elzein, et al.
Allergologia Et Immunopathologia|February 8, 2003
Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levelsB E Del-Río-Navarro, J J Luis Sienra-Monge, A Berber, et al.
Free Radical Biology & Medicine|March 25, 2015
Plasmalogen phospholipids protect internodal myelin from oxidative damageAdrienne M Luoma, Fonghsu Kuo, Ozgur Cakici, et al.
Semergen|August 11, 2019
[Blood glucose control and cardiovascular risk factors in type 2 diabetic patients with cardiovascular disease in Spain, and its treatment pattern, according to gender: CODICE study]M C Gómez García, J Franch-Nadal, J M Millaruelo Trillo, et al.
CNS Drugs|September 6, 2022
Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label StudyJai Perumal, Roumen Balabanov, Ray Su, et al.
Frontiers in Public Health|July 3, 2025
The growing impact of human papilloma virus (HPV)-associated cancers in men in Costa Rica: epidemiological and economic burdenSebastian Ospina-Henao, Francisco Brenes-Castillo, Marcel Marcano-Lozada, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 13, 2023
Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumabMark Gudesblatt, Myassar Zarif, Barbara Bumstead, et al.
Multiple Sclerosis and Related Disorders|April 21, 2021
Real-world propensity score comparison of treatment effectiveness of peginterferon beta-1a vs. subcutaneous interferon beta-1a, glatiramer acetate, and teriflunomide in patients with relapsing-remitting multiple sclerosisAnthony T Reder, Nancy Arndt, Cortnee Roman, et al.
Journal of Medicinal Food|May 23, 2009
Anti-inflammatory activity of aqueous and alkaline extracts from mushrooms (Agaricus blazei Murill)Marina M Padilha, Ana A L Avila, Pergentino J C Sousa, et al.
Pageof 28